5,0
4. Juni 2019
Ehemaliger Mitarbeiter, mehr als 1 Jahr
Morristown, NJ
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
I have been involved/exposed to a broad range of regulatory and scientific research services including: FDA Advisory Committee meetings (prescription drugs, biologics, nonprescription drugs), regulatory submissions (NDA, ANDA, BLA), type B and type C Meetings, Rx-To-OTC switch submissions, label updates, white papers, manuscripts. A true learning/rewarding experience. Very smart and skilled partners!
Kontras
Make sure to learn as quickly as possible how to work extra smart rather extra hours